Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
This article simplifies altcoins that beginners find approachable, outlining key features, how they differ from BTC, and practical steps to research safely.
20,805 articlesBiotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Two iconic automakers face two different futures. This analysis breaks down why Ford may offer a stronger industrial ...
America’s debt has surged to WWII-era levels even as growth accelerates. Here’s what the numbers show and why investo...
U.S. prosecutors in New York investigate links between Colombia's president and drug traffickers, while the DEA desig...
Mega-cap tech now drives most S&P 500 gains, leaving the rest of the market with thinner support. Here’s what investo...
As April 10 approaches, investors debate whether Lilly stock is a buy. This guide breaks down catalysts, valuation, a...
A new GROK AI forecast linked to Elon Musk projects XRP could surge to several dollars by 2026, contingent on regulat...
Pet owners are delaying routine vet visits to save money, yet expensive emergency surgeries keep pet-health firms in ...
AI-driven investment has become a major growth engine for the U.S. economy, but a slowdown could ripple across jobs, ...
Investors are weighing when the Fed will cut rates again and how those moves could reshape stock returns and portfoli...
A tiny insider sale can spark big questions. This article explains what’s behind $211,680 sale, how Vicor’s AI-led de...
A bold plan unfolds as a European crypto treasury targets triple BTC holdings by buying two specialist firms. The mov...